TerminatedPhase 2ACTRN12618000957291

The clinical efficacy of non-surgical periodontal debridement alone, adjunctive systemic azithromycin, or amoxicillin-metronidazole therapy in patients with chronic moderate-to-advanced periodontitis

Comparing the periodontal tissue response to non-surgical scaling and root planing alone, adjunctive azithromycin, or adjunctive amoxicillin plus metronidazole in generalised chronic moderate-to-severe periodontitis: a preliminary randomised controlled trial.

Sponsor

Andrew Liaw

Enrollment

78 participants

Start Date

Jul 6, 2016

Study Type

Interventional

Conditions

Periodontitis

Summary

The administration of systemic antibiotic adjuncts following scaling and root planing to further expedite healing of the periodontal tissues is a topic of considerable interest, given the lack of evidence-based guidelines for their use in periodontal treatment. The aim of this study was to evaluate and compare the clinical and inflammatory cytokine effects between scaling and root planing alone, adjunctive azithromycin, or adjunctive amoxicillin plus metronidazole in the treatment of patients with generalised moderate-to-severe chronic periodontitis. It was initially hypothesized that patients receiving scaling and root planing + azithromycin would demonstrate greater reductions in clinical attachment level (greater than or equal to 1 mm) and inflammatory cytokine levels compared to the other treatment groups, after 2 months.

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 70 Yearss

Inclusion Criteria3

All patients were in good general health and were diagnosed with generalised moderate-to-severe chronic periodontitis based on the current classification of the American Academy of Periodontology:
At least 16 natural teeth (excluding third molars and teeth with advanced caries indicated for extraction).
More than 30% of teeth probing pocket depth greater than or equal to 5mm, clinical attachment level greater than or equal to 3mm, and bleeding on probing at baseline.

Exclusion Criteria7

Pregnancy and lactation.
Active tobacco smoking.
Scaling and root planing or antibiotic therapy within the last six months.
Medical disorders that require prophylactic antibiotic coverage or that could influence the progression or treatment of periodontitis
Long term administration of anti-inflammatory or immunosuppressive medications
Positive history of cardiovascular disease
Known hypersensitivity to amoxicillin, metronidazole or amoxicillin.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Arm 1: Ultrasonic and manual full-mouth scaling and root planing (2 x 90 min sessions within 7 days) alone. Arm 2: Ultrasonic and manual full-mouth scaling and root planing (2 x 90 min sessions withi

Arm 1: Ultrasonic and manual full-mouth scaling and root planing (2 x 90 min sessions within 7 days) alone. Arm 2: Ultrasonic and manual full-mouth scaling and root planing (2 x 90 min sessions within 7 days), plus amoxicillin 500mg and metronidazole 400mg, three times a day for seven days; administered via oral tablets. Arm 3: Ultrasonic and manual full-mouth scaling and root planing (2 x 90 min sessions within 7 days), plus azithromycin 500mg once a day for three days; administered via oral tablet. The intervention drugs were administered by a third party clinician (dental hygienist) with no involvement in the study. Adherence and any adverse events were reported by the patient via an anonymous written survey given out at 1 week follow-up.